Search clinical trials for: AVANZ Phleum pratense 15,000 SQ

Total 72 results

ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
Bispebjerg Hospital
ALK-Abelló A/S

Completed

Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen

Allergic Rhinitis Due to Grass Pollens

Denmark
ALK-Abelló A/S

Completed

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Avanz Phleum Pratense Maintenance Dose

Allergic Rhinoconjunctivitis

Germany
Novartis Pharmaceuticals

Completed

A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance

Seasonal Allergic Rhinitis

United Kingdom
Imperial College London
ALK-Abelló A/S

Unknown

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Rhinitis, Allergic, Seasonal

United Kingdom
University of Aarhus

Completed

Effect of Intralymphatic Immunotherapy

Allergy | Immune Tolerance | Injection Site Discomfort

Denmark
Imperial College London
ALK-Abelló A/S

Completed

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Rhinitis, Allergic, Seasonal

United Kingdom
Rigshospitalet, Denmark
TRYG Foundation

Completed

Study to Asses Efficacy of Intralymphatic Immunotherapy (ILIT)

Allergy

Denmark
ALK-Abelló A/S
Ergomed; ACM Pivotal Global Central Laboratory; Brecon Pharmaceuticals Ltd

Completed

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense (Osiris)

Rhino-conjunctivitis

Poland
Aarhus University Hospital
University of Aarhus; ALK-Abelló A/S; Lundbeck Foundation

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Allergic Rhinoconjunctivitis
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain
Aarhus University Hospital
University of Aarhus; University Hospital, Linkoeping

Active, not recruiting

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy (ILITNU)

Allergic Rhinitis Due to Grass Pollen | Allergic Asthma | Allergic Conjunctivitis of Both Eyes

Denmark, Sweden
Abbott

Completed

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinitis

Russian Federation
ALK-Abelló A/S

Completed

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

Conjunctivitis | Rhinitis Allergic
Zentrums für Rhinologie und Allergologie Wiesbaden
University Hospital of Cologne

Completed

Titrated Quantitative Conjunctival Provocation Test (tqCPT) (tqCPT)

Allergic Rhinitis
Imperial College London
King's College London; Wellcome Trust; ALK-Abelló A/S

Completed

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study (Pollen+)

Allergic Rhinitis

United Kingdom
Bial - Portela C S.A.

Completed

Effect of Food on BIA 5-1058

Pulmonary Arterial Hypertension
Leti Pharma GmbH

Completed

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | Sensitization Against Phleum Pratense Pollen | Dose-Finding Study

Germany
Bial - Portela C S.A.

Completed

Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

Pulmonary Arterial Hypertension

Germany
Turku University Hospital
Academy of Finland; Juselius Foundation, Helsinki, Finland; Foundation for Paediatric... and other collaborators

Unknown

Tonsillar Cytokine Expression After Allergen and/or Virus Intervention (Tons2)

Healthy

Finland
Pfizer

Completed

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

Seasonal Allergic Rhinitis

United Kingdom
Bial - Portela C S.A.

Completed

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Pulmonary Arterial Hypertension

Germany
Tufts University

Completed

Determinants of Vitamin K Metabolism

Aging | Osteoporosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Ultra Low Dose Interleukin-2 in Healthy Volunteers

Hematologic Diseases

United States
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Vasodilatory Shock

China
Viriom

Completed

Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

HIV-infection

Thailand
Takeda

Active, not recruiting

A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Multiple Myeloma | Autologous Stem Cell Transplant

United States, Spain, Australia, Czechia, Hungary, Taiwan, Italy, Denmark, Portugal, Singapore, Israel, Canada, France, Belgium, United Kingdom, Germany, Japan, Austria, Netherlands, Korea, Republic of, Poland, Greece, Colombia, Sweden, South Africa and more
Celltrion

Completed

A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

Healthy

Korea, Republic of
University of California, San Diego
Takeda; Celgene; Janssen, LP

Active, not recruiting

Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

United States
China Academy of Chinese Medical Sciences
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Completed

Causal Inference Research of Resistant Hypertension Treatment With Chinese Approach in a Cohort Study

Hypertension, Resistant to Conventional Therapy | Primary Hypertension

China
International Bio service

Not yet recruiting

The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

Healthy Volunteer
AstraZeneca
Parexel

Completed

A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Type 2 Diabetes Mellitus

United States
GL Pharm Tech Corporation

Completed

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers

Healthy

Korea, Republic of
Genuine Research Center, Egypt
Eva Pharma

Completed

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

Healthy

Egypt
Max Zeller Soehne AG

Completed

Investigation of Efficacy and Safety of EPOGAM

Atopic Dermatitis | Neurodermatitis

Switzerland
GL Pharm Tech Corporation

Completed

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)

Healthy

Korea, Republic of
Reseach Laboratory of Clinical and Experimental...
La Société Arabe des Industries Pharmaceutiques-Tunisie; Centre National Chalbi...

Completed

Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet®

Fed Conditions

Tunisia
Merck Sharp & Dohme LLC

Completed

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)
AET Laboratories Private Limited

Completed

The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.

To Determine Bioequivalence Under Fed Conditions
Vastra Gotaland Region
Octapharma

Withdrawn

Atenativ Effect on Uterine Blood Flow and Preeclampsia

Antithrombin III Deficiency

Sweden
Damanhour University
Tanta University

Completed

Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD

Coronary Artery Disease | Diabetes Mellitus, Type 2

Egypt
University of California, San Francisco

Completed

Effects of Gastric pH on the Pharmacokinetics of Atazanavir

Healthy

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Switzerland, Germany
Merck Sharp & Dohme LLC

Completed

A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)

Type 2 Diabetes
Uppsala University
Lund University

Completed

Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART (VALIDATE)

ST-segment Elevation Myocardial Infarction | Non ST-segment Elevation Myocardial Infarction

Sweden
Galenicum Health

Completed

Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers

Type 2 Diabetes | Bioequivalence

Canada
Galenicum Health

Completed

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Diabetes Mellitus, Type 2 | Bioequivalence

Mexico

Search clinical trials for: AVANZ Phleum pratense 15,000 SQ

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations